WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

The US Senate has moved to spare the world’s biggest HIV treatment and prevention programme – which funds drugs and research in more than 50 countries – from $400m (£298m) of aid cuts imposed by ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

KIGALI, July 17 (Xinhua) -- Health experts are calling on governments around the world to increase funding for HIV research and community-led responses, warning that current funding cuts risk ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

The International AIDS Society (IAS) on Sunday called on President Trump to increase funding for AIDS research, warning that his proposed spending cuts could cause deaths. IAS president Linda-Gail ...